This article delves into the critical role of clinical trials in combating major health crises. It elucidates the multifaceted challenges impeding clinical trials, including patient recruitment, funding, and data management issues....
An experimental cancer drug might be able to help prevent the organ damage caused by severe COVID infections, a new study finds....
Wisconsin was named a “tech hub,” a process that began with the 2022 passage of the CHIPS and Science Act and which spurred a multi-state competition for federal dollars. The Economic Development Administration designated 12 such hubs, spread among sectors ranging from quantum computing to...
Now, a coalition of biohealth businesses, colleges and economic development agencies is getting $49 million in federal funds to solve those problems and more....
A promising therapy that treats blood cancers by harnessing the power of the immune system to target and destroy cancer cells could now treat solid tumors more efficiently....
Following a rigorous selection process, the EDA has awarded the Wisconsin Biohealth Tech Hub with $49 million in federal grants to support transformative projects aligned with the program’s overarching goal....
Diversity action plans—focused on enrolling representative numbers of participants in clinical trials from historically underrepresented racial and ethnic populations—are part of U.S. Food and Drug Administration (FDA) draft guidance published in April 2022....
UW Health’s Carbone Cancer Center in Madison is making incredible progress in cancer treatment, offering new hope to many patients....
UW Health recently earned seven national awards from Practice Greenhealth, a nonprofit organization focused on making the health care industry more sustainable....
Today, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist medical product sponsors in submitting Diversity Action Plans to support certain clinical studies....
